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Abstract
Background: Cysteine proteases have been shown to be highly relevant for Apicomplexan parasites. In the case of
Babesia bovis, a tick-transmitted hemoparasite of cattle, inhibitors of these enzymes were shown to hamper
intraerythrocytic replication of the parasite, underscoring their importance for survival.
Results: Four papain-like cysteine proteases were found to be encoded by the B. bovis genome using the MEROPS
database. One of them, the ortholog of Plasmodium falciparum falcipain-2, here named bovipain-2, was further
characterized. Bovipain-2 is encoded in B. bovis chromosome 4 by an ORF of 1.3 kb, has a predicted molecular
weight of 42 kDa, and is hydrophilic with the exception of a transmembrane region. It has orthologs in several other
apicomplexans, and its predicted amino acid sequence shows a high degree of conservation among several B. bovis
isolates from North and South America. Synteny studies demonstrated that the bovipain-2 gene has expanded in the
genomes of two related piroplasmids, Theileria parva and T. annulata, into families of 6 and 7 clustered genes
respectively. The bovipain-2 gene is transcribed in in vitro cultured intra-erythrocyte forms of a virulent and an
attenuated B. bovis strain from Argentina, and has no introns, as shown by RT-PCR followed by sequencing.
Antibodies against a recombinant form of bovipain-2 recognized two parasite protein bands of 34 and 26 kDa, which
coincide with the predicted sizes of the pro-peptidase and mature peptidase, respectively. Immunofluorescence
studies showed an intracellular localization of bovipain-2 in the middle-rear region of in vitro cultured merozoites, as
well as diffused in the cytoplasm of infected erythrocytes. Anti-bovipain-2 antibodies also reacted with B. bigemina-
infected erythrocytes giving a similar pattern, which suggests cross-reactivity among these species. Antibodies in sera
of two out of six B. bovis-experimentally infected bovines tested, reacted specifically with recombinant bovipain-2 in
immunoblots, thus demonstrating expression and immunogenicity during bovine-infecting stages.
Conclusions: Overall, we present the characterization of bovipain-2 and demonstrate its in vitro and in vivo
expression in virulent and attenuated strains. Given the involvement of apicomplexan cysteine proteases in essential
parasite functions, bovipain-2 constitutes a new vaccine candidate and potential drug target for bovine babesiosis.
Background
The tick-transmitted apicomplexan hemoprotozoon
Babesia bovis continues to impose serious limitations to
cattle development worldwide [1,2]. A better understand-
ing of its pathogenic mechanisms and the exploitation of
the recently sequenced genome [3] is needed for the
identification of molecules that are involved in the host-
pathogen and vector-pathogen interface, which can lead
to improved control strategies against this parasite.
The search for relevant parasite molecules can benefit
from the information available for Plasmodium falci-
parum, another arthropod vector-transmitted apicom-
plexan protozoon with an intraerythrocytic life stage, that
shares pathogenicity mechanisms with B. bovis [4]. Plas-
modial peptidases have been shown to play vital func-
tional roles and have been proposed as vaccine
candidates [5]. The best characterized P. falciparum
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any medium, provided the original work is properly cited.peptidases are the falcipains, which are cysteine pepti-
dases that belong to clan CA, subfamily C1A.
Assortment of peptidases into clans is based on the
presence of sequence motifs around the catalytic resi-
dues, their evolutionary relationships and/or similarities
in their tertiary structure. Clans, in turn, are subdivided
in families, according to their amino acid sequence simi-
larities. Cysteine peptidases of clan CA utilize catalytic
glutamine, cysteine, histidine and asparagine residues
that are invariably in this order [6]. These four amino
acids are present in three separate, well conserved
regions of the primary sequence that correspond to the
mature protease, which are known as the eukaryotic
thiol (cysteine) proteases cysteine, histidine, and aspara-
gine active site regions.
Falcipain-2 has shown to be involved in digestion of
host erythrocyte hemoglobin in the parasite food vacuole
[ 7 , 8 ] .T h ea m i n oa c i d st h a tr e s u l tf r o mt h i sp r o c e s sa r e
used for parasite protein synthesis [9,10], and contribute
to maintain the osmotic stability of the parasite [11].
Hemoglobin degradation might provide space for the
g r o w t ho ft h ep a r a s i t ei n s i d et h ee r y t h r o c y t e[ 1 2 ] .A d d i -
tionally, falcipain-2 has been shown to cleave host ery-
throcyte membrane skeletal proteins ankyrin and protein
4.1. The removal of the carboxyl terminus of ankyrin
weakens its interaction with the erythrocyte membrane
and yields an increased rate of membrane fragmentation
of infected erythrocytes [13]. In addition, falcipain-2
cleaves protein 4.1 within a region of the spectrin-actin
binding domain critical for erythrocyte membrane stabi-
lity [14]. It has been postulated that the proteinase-
induced ankyrin and protein 4.1 degradation destabilizes
the erythrocyte membrane skeleton, which in turn facili-
tates parasite release [15]. Furthermore, it has been
shown that cysteine peptidases might be involved in the
differentiation of plasmodial gametocytes into ookinetes.
Torres et al [16] demonstrated that serine/cysteine pro-
tease inhibitors TPCK and TLCK, but not the serine pro-
tease specific inhibitors PMSF and leupeptin, inhibited
exflagellation centers formation, suggesting a participa-
tion of cysteine proteases in P. berghei gamete activation
and zygote development.
Cysteine proteinases have been shown to play critical
roles in the pathogenicity of other parasitic protozoans
as well. Thus, they have been identified as virulence fac-
tors in Leishmania amazonensis and Entamoeba histoly-
tica [17,18]. Virulence is intimately associated with
proteolysis and invasion of cells and/or tissues by intra-
cellular and extracellular parasites [19]. Accordingly,
cysteine proteinases of Toxoplasma gondii and Trypan-
soma cruzi h a v eb e e nf o u n dt ob ei n v o l v e di nh o s tc e l l
and tissue invasion and egress [18,20]. Adherence of
E. histolytica to erythrocytes and epithelial cells as well
as excystation processes of Cryptosporidium sp. and
Giardia sp. [18] have been shown to be mediated by
parasite cysteine proteinases.
This type of enzyme is ubiquitous in all kingdoms of
organisms. In mammals, cysteine proteinases function in
diverse processes like apoptosis, prohormone processing,
tissue remodelling, turnover of the extracellular matrix,
and extracellular degradation of foreign proteins [21,22].
Importantly, lysosomal cysteine peptidases also regulate
the immune response by mediating antigen presentation
of classical MHC class II and non-classical MHC class-I
molecule CD1D [23].
Cysteine peptidases have so far not been characterized
in B. bovis. However, evidence of their importance for
the survival of these parasites was obtained by the obser-
vation that specific inhibitors of these enzymes impaired
merozoite growth in vitro [24]. As in P. falciparum,
cysteine peptidases may be involved in the erythrocyte
egress of B. bovis merozoites, a prerequisite for the main-
tenance of the asexual propagation of the parasite, and/or
nutrition of the trophozoite and merozoite parasite stages
that reside within the erythrocyte through degradation of
hemoglobin. Additionally, B. bovis cysteine peptidases
may also play an important role in several differentiation
steps of the parasite (sporozoite, trophozoite, merozoite,
kinete) as well as in invasion and evasion processes
within the tick vector tissues.
The aim of this work has been to identify and charac-
terize the falcipain-2 ortholog in B. bovis,a sw e l la st o
make an inventory of cysteine proteinases in this para-
site and two related piroplasmids.
Results
Identification of putative cysteine peptidases of the C1
family in the B. bovis T2Bo genome
Four putative cysteine peptidases of clan CA, subfamily
C1A [6], were identified in the B. bovis T2Bo predicted
proteome. Two of these cysteine proteinases belong to
the family of dipeptidylpeptidase I of the Plasmodium-
type [MEROPS:C01.124] which is confined to protozo-
ans. This type of cysteine proteinases is composed of the
cathepsin C exclusion domain, whose function is to pre-
vent the approach of a polypeptide apart from its termini,
and the catalytically active cysteine peptidase region. The
remaining two cysteine proteinases were found to be
papain homologues of the Theileria-type. This type of
proteases are synthesized as inactive proenzymes and
proteolytic cleavage of the inhibitor region [MEROPS:
I29.UPW] is required for activation of the peptidase C1
unit [MEROPS:C01.079]. Apart from protozoans, this
type of papain-like cysteine proteinases has also been
found in other eukaryotes. The identification number,
chromosome location, current annotation status, pre-
dicted protein size and active site region localization of
these four cysteine peptidases are shown in Table 1.
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Among the four predicted cysteine proteases mentioned
above, the peptide XP_001610695 showed to be ortholo-
gous to P. falciparum falcipain-2. According to current
nomenclature standards, this protein is referred to as bovi-
pain-2 in this work. Bovipain-2 orthologs are present in
B. bigemina, T. annulata, T. parva, P. knowlesi,a n d
P. vivax (Table 2). A very high E value was also found
with a cysteine peptidase of T. orientalis (E value, 7e-73)
and B. equi also known as T. equi [25] (E value, 3e-70),
however, as the complete genome sequence of these two
organisms is not available, orthology could not be
established.
The bovipain-2 encoding gene is located half way
between the centromere and the 3’ telomere of chromo-
some 4. It is surrounded, upstream, by a gene encoding a
GTP-binding protein and, downstream, by a gene encod-
ing a hypothetical membrane protein (Figure 1). No other
peptidase-encoding genes are found in close vicinity. The
bovipain-2 ORF is 1338 bp long, and encodes for a puta-
tive protein with a calculated molecular weight of 42 kDa.
Secondary structure prediction of the bovipain-2 ORF
showed three distinct regions: an N-terminal hydrophilic
region of 43 amino acids (aa), predicted to be located in
an aqueous compartment at one side of a membrane, a
22 aa-long hydrophobic transmembrane domain, and a
380 aa-long region at the opposite side of the membrane
that extends to the C-terminus. Domain predictions
(Figure 2) showed the typical prepropeptide organization
of cysteine proteases of the papain family, including a 43
aa-long signal peptide, a 24 aa transmembrane domain,
a spacer, and a 320 aa-long propeptide (which corre-
sponds to a predicted molecular weight of 34 kDa). This
propeptide is composed of a cysteine peptidase inhibitor,
a spacer and a 209 aa-long mature enzyme of an esti-
mated molecular weight of 26 kDa.
Post-translational modification of 3 sites that are
potentially N-glycosylated (N113, N198, and N221) and
1 site that is potentially O-glycosylated (T204) could be
predicted based on sequons in the propeptide/spacer
region of bovipain-2. As the available bioinformatic
tools have been developed for mammalian organisms,
the validity of these predictions in Babesia needs to be
verified by direct experimental evidence.
The mature enzyme owns three stretches of amino
acids that contain the catalytic residues (Q254, C260,
H389, and N411). Upon folding, these amino acid
sequences configure the 3D structure of the catalytic cen-
ter of the proteinase. These three stretches are known
as 1) eukaryotic thiol (cysteine) proteases cysteine
(aa 254 to 265), 2) histidine (aa 387 to 397), and 3) aspar-
agine (aa 406 to 425) active site regions, since these
Table 1 Babesia bovis cysteine peptidase C1 family
GenBank Id Annotation Chr Predicted protein
length (aa)
Catalytic region
localization
MEROPS annotation of catalytic region
XP_001610695 cysteine protease 2 4 445 235-444 papain homolog (Theileria type)
(C01.079)
XP_001612131 papain family cysteine
peptidase
3 435 135-426 papain homolog (Theileria type) (C01.079)
XP_001609546 cathepsin C precursor 2 530 261-511 dipeptidylpeptidase I (Plasmodium type)
(CO1.124)
XP_001608716 cathepsin C precursor 1 546 279-530 dipeptidylpeptidase I (Plasmodium type)
(CO1.124)
All putative cysteine peptidases were identified in the B. bovis T2B predicted proteome using the MEROPS database. Protein identification number, current
Genbank annotation, chromosome (chr), predicted protein length, catalytic protein localization, and MEROPS annotation of the catalytic region of those putative
proteins belonging to the C1 family are shown.
Table 2 Babesia bovis bovipain-2-related proteins in other apicomplexan organisms
GenBank Id Organism Annotation % identity Bovipain-2 ortholog Ref.
ACO94081 Babesia bigemina babesipain-1 48.5 Yes 1
BAD08222 Theileria orientalis cysteine peptidase 2 36.6 NA -
XP_954970 T. annulata cysteine peptidase precursor, tacP 36.6 Yes 2
XP_763298 T. parva cysteine proteinase 36.5 Yes 3
AAC17994 B. equi cysteine peptidase 35.0 NA 4
XP_001615274 Plasmodium vivax vivapain-2 29.3 Yes -
XP_002259153 P. knowlesi falcipain ortholog 28.8 Yes 5
XP_001347832 P. falciparum falcipain-2B 28.5 Yes 6
Proteins with the highest scores of identity with bovipain-2 amino acid sequence (T2B strain) are shown. A Blosum 62 matrix was used to calculate identity
percentages. Orthology was established by reverse BLAST against available genome sequences of corresponding organisms. NA: not applicable as the complete
genome sequence was not available. References (Ref.) are as follows: (1) [35]; (2) [57]; (3) [58]; (4) [59]; (5) [26]; (6) [60].
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sequence is highly conserved among several apicom-
plexan parasites, as shown in Figure 2.
Bovipain-2 predicted amino acid sequences encoded in
t h eg e n o m eo fd i f f e r e n tB. bovis geographic isolates
from USA, Argentina, Uruguay and Brazil and Mexico
were aligned and compared (data not shown). A high
percentage of overall identity (97.8%) was observed
among these sequences, with polymorphism in 10 sites
(Table 3). All ten of these amino acid substitutions are
conservative, and were in silico predicted not to affect
protein function, as the exchanged amino acids have
similar physico-chemical characteristics.
Synteny and phylogenetic studies with Theileria annulata
and T. parva cysteine peptidases
T h ep h y l o g e n e t i cr e l a t i o n s h i p so ft h ef o u ri d e n t i f i e d
putative cysteine peptidases of B. bovis and related
orthologs and/or paralogs of T. annulata and T. parva
were, analyzed (Figure 3A). Clades 1, 3, and 4 each con-
tain one B. bovis cysteine peptidase with their respective
T. annulata and T. parva orthologous counterpart.
Orthology of the protein sequences in clades 1, 3, and 4
were also confirmed by a reverse BLAST test. In con-
trast, clade 2, contains the B. bovis cysteine peptidase
defined in this work as bovipain-2, as well as an evolu-
tionary closely related family of 7 T. annulata and 6
T. parva cysteine proteinases (Figure 3B). Comparative
genomics of the bovipain-2 coding region of B. bovis
with corresponding cysteine proteinase encoding regions
of T. annulata,a n dT. parva genomes demonstrated
that the bovipain-2 gene has expanded into a gene
family of 7 and 6 cysteine proteinase encoding genes,
respectively. Both gene families are clustered and have
possibly originated from several gene duplication events.
It is noteworthy that a small ORF encoding a hypotheti-
cal protein [GenBank: XP_001610696] that is lying
downstream of the bovipain-2 encoding gene in B. bovis
has high scoring sequence pairs (HSPs) in T. annulata
and T. parva. However, only in T. parva,b u tn o ti n
T. annulata this ORF has been annotated. This highly
likely represents an example of a mis-annotation as this
ORF has been reported to be conserved in apicom-
plexan parasites [26].
Transcription and expression of bovipain-2 in B. bovis
in vitro cultured merozoites
RT-PCR, using total RNA from in vitro cultured parasites
from the Argentine virulent strain BboS2P (Figure 4) and
the attenuated strain BboR1A (not shown) as template,
demonstrated that the bovipain-2 gene is transcribed in
intra-erythrocytic stages of both strains. Sequence com-
parison between the DNA and the resulting cDNA
sequences showed the absence of introns.
Antibodies against a recombinant form of bovipain-2
recognized at least two distinct proteins of in vitro cul-
tured merozoites of the BboS2P strain in immunoblots.
Two bands of 26 and 34 kDa were observed, which
coincide with the expected sizes of the proenzyme and
the mature enzyme, respectively (Figure 5A).
Immunofluorescence confirmed the expression and
intracellular localization of bovipain-2 in in vitro cul-
tured merozoites from an Argentine (BboS2P) and a
Mexican (RAD) strains (Figure 6A and 6B). Fluores-
cence microscopy analysis indicated that the signal
appeared concentrated in a dense spot, in the middle-
rear region of the cell (Figure 6B). Additionally, diffuse
fluorescence was also observed in the cytoplasm of ery-
throcytes infected with merozoites of either strain, but
not in non-infected erythrocytes (Figure 6F), thus
demonstrating that the pattern of fluorescence observed
was bovipain-2-specific and not due to possible cross-
reaction with erythrocyte proteins. As expected [27],
Figure 1 Localization of the bovipain-2 gene in the genome of
the Babesia bovis strain T2Bo. A. Schematic representation of
chromosome 4 of the B. bovis strain T2Bo showing the relative
localization of the bovipain-2 encoding gene. The localization of the
centromere and telomeres are indicated by arrows. B. Organization
of the B. bovis ~39.4 kbp genomic region containing the locus of
bovipain-2. The orientation of the open reading frames (ORF) is
shown with black arrows. IG: intergenic regions.
Figure 2 Domain prediction of bovipain-2.P u t a t i v ef u n c t i o n a l
domains in bovipain-2 were predicted based on the amino acid
sequence of the T2B strain. The numbers indicate the eukaryotic
thiol (cysteine) proteases cysteine (1); histidine (2) and asparagine
(3) catalytic regions. Amino acids in bold represent active sites
(Q254, C260, H389, N411). Sequence alignments of these three
regions in several Babesia, Theileria and Plasmodium spp. are shown.
Arrows indicate amino acids of the active site.
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antibodies tested on the same smears yielded a punctu-
ated pattern, with no erythrocyte cytoplasm reaction
(Figure 6D), and normal mice serum gave no signal
(Figure 6E). B. bigemina merozoites of an Argentine
(BbiS2P) (not shown) and a Mexican (Mexico strain)
strain (Figure 6C) also reacted with anti-bovipain-2 anti-
bodies, as shown by immunofluorescence, yielding a
similar pattern to that observed for B. bovis.T h u s ,t h e
immunofluorescence data indicates that bovipain-2 is
expressed in intra erythrocytic stages of B. bovis.
Antigenicity of bovipain-2 in B. bovis-infected cattle
Partially purified recombinant bovipain-2 was tested in
immunoblots against serum samples from bovines
experimentally infected with the BboS2P (n = 3) or the
BboR1A (n = 3) strains of B. bovis (day 63 p.i.). Non
B. bovis-reactive sera from two bovines from a tick-free
region of Argentina were used as negative controls.
Only one of the BboS2P-infected and one of the
BboR1A-infected sera reacted with recombinant bovi-
pain-2 (Figure 5B), while all BboS2P and BboR1A sera
strongly reacted with recombinant MSA-2c (not shown),
a previously characterized immunodominant protein of
B. bovis [28]. These results indicate that bovipain-2 is
expressed and immunogenic in the course of bovine
infections with these two strains.
Discussion
P. falciparum falcipain-2 has received a great amount of
attention as a target for therapeutic interventions against
malaria, due to its relevant functional role [29]. This
work identifies and characterizes bovipain-2, the B. bovis
ortholog of falcipain-2. The biological significance of
this protein is underscored by the observation that
B. bovis growth can be inhibited using cysteine-protei-
nase inhibitors [24].
Based on their sequences, falcipain-2 and bovipain-2
are classifiable as cysteine peptidases belonging to Clan
CA, subfamily C1A. This peptidase subfamily is charac-
terized by the presence of four catalytic Q, C, H, and A
residues present in three separate, well conserved
regions of the primary sequence that corresponds to the
mature protease, which are known as the eukaryotic
thiol (cysteine) proteases cysteine, histidine, and aspara-
gine active site regions (Figure 2). In the final tertiary
conformation of the protein, the catalytic amino acids
are brought together and constitute the enzyme active
site. Importantly, predicted models of the putative cata-
lytic site in falcipain-2 and bovipain-2 showed a similar
arrangement of the relevant C, H, and N regions that
f o r mt h ea c t i v es i t eo ft h ee n z y m ei nb o t hp r o t e i n s ,
despite high sequence polymorphisms in the intervening
regions (data not shown). Furthermore, alignment of
bovipain-2 orthologs from different apicomplexan para-
sites showed strict conservation of the catalytic residues
and low polymorphism in their surrounding areas
(Figure 2). Additionally, full sequence conservation was
observed among bovipain-2 protein sequences of
B. bovis geographical isolates in the whole region that
harbors the active site. This constraint for genetic varia-
tion is likely due to the need for keeping the structural
conformation of the protein in order to preserve its
activity. Thus, taken together these data support a
cysteine protease function for bovipain-2, similar to
what was previously described for falcipain-2.
Interestingly, apart from bovipain-2, only 3 other C1
cysteine proteinase encoding genes seem to be present in
the B. bovis-genome. The bovipain-2 encoding gene cor-
responds to gene families in T. annulata and T. parva of
7 and 6 members, respectively. In contrast, the other
cysteine proteinase encoding genes of B. bovis have a sin-
gle ortholog equivalent in T. parva and T. annulata.W e
hypothesize that the expanded cysteine-protease family
Table 3 Strain polymorphism of bovipain-2
Strain/isolate GenBank Id Position of polymorphic amino acid residue
71 76 89 121 139 145 201 365 401 420
T2Bo BBOV_IV007730 S S N V T TVAA D
BboR1A GQ412131 S S N V S SIG A D
BboS2P GQ412136 GAS I S S VATD
BboM3P GQ412133 S S N V T TVATD
Brazil GQ412132 S S S VSTI ATE
Uruguay GQ412134 S S S VSTIGAD
Veracruz GQ412135 S S N V T TVATD
Common physico-chemical characteristics s s p;s a p;s p;s a s;h s;h n
The complete bovipain-2 coding sequence of different isolates was sequenced. The table shows the polymorphic sites and the amino acid substitutions, after
alignment of predicted peptide sequences. Amino acid polymorphic positions within the active site region are in italics. The least frequent substitution in each
column is in bold. Common physico-chemical characteristics of amino acids found at each polymorphic site are depicted in the last row: p: polar; a: aliphatic; h:
hydrophobic; s: small or tiny; n: negatively charged. Single-letter amino acids code was used.
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 Bb XP_001612131
 Ta XP_952571
 Tp XP_764709
orthologs group 1
 Bb XP_001610695
 Ta XP_954973
 Tp XP_763300
 Ta XP_954971
 Ta XP_954970
 Tp XP_763298
 Ta XP_954975
 Tp XP_763302
 Ta XP_9549761
 Tp XP_763303
 Ta XP_954974
 Tp XP_763301
 Ta XP_954972
 Tp XP_763299
orthologs group 2
 Bb XP_001609546
 Ta XP_955044
 Tp XP_763377
orthologs group 3
 Bb XP_001608716
 Ta XP_951829
 Tp XP_765451
orthologs group 4
 Lm XP_001681130
100
100
100
83
85
100
100
100
100
98
100
100
73
100
56
82
71
37
44
32
10
0.2
B 
Figure 3 Phylogenetic and synteny relationships between B. bovis, T. annulata and T. parva C1 cysteine peptidases.A .P h y l o g e n e t i c
relationships of cysteine peptidases of B. bovis and their Theileria annulata and T. parva orthologs/paralogs as analyzed by neighbor joining. The
tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The
evolutionary distances were computed using the Poisson correction method. Deletion of all positions containing gaps and missing data resulted
in a total of 171 positions in the final dataset. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap
test (1000 replicates) is shown next to the branches. The GenBank reference sequence number of each protein is shown. Bb: B. bovis; Ta: Theileria
annulata; Tp: T. parva; Lm: Leishmania major cathepsin L-like protein is used as outgroup. B. Synteny studies of the bovipain-2 encoding genome
region with the ortholog/paralogs encoding regions of T. annulata and T. parva. Lines that connect the catalytic region of the bovipain-2
[GenBank: XP_001610695] encoding gene and the catalytic regions of related cysteine proteinases encoding genes of T. annulata, and T. parva
represent high scoring sequence pairs (HSPs). Reference protein sequence numbers from right to left: T. annulata, [GenBank: XP_954970,
XP_954971, XP_954972, XP_954973, XP_954974, XP_954975, XP_954976], and T. parva, [GenBank: XP_763298, XP_763298, XP_763298, XP_763298,
XP_763298, XP_763298]. A small ORF encoding a hypothetical protein [GenBank XP_001610696] in B. bovis has corresponding HSPs in
T. annulata and T. parva.I nT. annulata this ORF has not been annotated.
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T. parva and T. annulata associated with the additional
schizont parasite stage and more complex life cycle of
Theileria sp. parasites. However, this notion would need
to be demonstrated in future investigations. Gene dupli-
cations and tandem arrays of similar isoforms of clan CA
peptidases have also been found in other related proto-
zoan parasites, but the biological implications of this phe-
nomenon remain unclear [30].
In P. falciparum falcipain-2 localizes in the food
vacuole, where hemoglobin digestion takes place [31].
However, falcipain-2 expression was detected also out-
side of the food vacuole and near the erythrocyte mem-
brane skeleton which is consistent with the proposed
involvement of erythrocyte membrane skeletal protein
cleavages in merozoite egress [15]. The punctate immu-
nofluorescence pattern shown in Figure 6 indicates that,
similar to its P. falciparum ortholog, bovipain-2 also
appears to be localized in a yet undefined, internal orga-
nelle of the parasite. Food vacuoles have been described
in Babesia sp. but only on the basis of morphological
evidence [32,33]. Thus, further investigations need to be
carried out to more exactly elucidate the intracellular
location of bovipain-2. However, similarly to Plasmo-
dium, anti-bovipain-2 antibodies also reacted with the
cytoplasm of B. bovis-infected erythrocytes of different
strains tested, while smears of non-infected erythrocytes
showed no reactivity. These observations suggest first,
that bovipain-2 and erythrocyte proteases do not share
cross-reactive B-cell epitopes and also, that bovipain-2 is
Figure 4 Transcription of the bovipain-2 gene.B o v i p a i n - 2
transcripts were detected by total RNA extraction of in vitro
cultured B. bovis merozoites (BboS2P strain), followed by incubation
with reverse transcriptase and PCR amplification of the complete
ORF (RT+). To rule out DNA contamination, an equal amount of
RNA was not incubated with reverse transcriptase and then treated
as above (RT-). 1 kb: DNA size standard. The size of the obtained
amplicon is marked at the left.
Figure 5 Expression and immunogenicity of bovipain-2.A .
Expression of bovipain-2 in in vitro cultured merozoites. Aliquots of
a merozoite suspension of the BboS2P strain of B. bovis were
electrophoresed, blotted and exposed to antibodies against (1)
recombinant bovipain-2, or (2) normal serum. Antibody binding was
detected by incubation with peroxidase-labeled anti-mouse IgG and
chemiluminiscence. Bands of 34 and 26 kDa correspond to the
expected sizes of bovipain-2 pro-protein and mature protein,
respectively. B. Immunogenicity of bovipain-2 in B. bovis-
experimentally infected cattle. Stripes with blotted, partially purified
bovipain-2 were incubated with sera from different bovines
experimentally infected (day 63 p.i.) with the BboR1A strain (stripes
1-3) or the BboS2P strain of B. bovis (4-6); non infected bovine sera
(8-9); or a monoclonal antibody that reacts with the histidine tag of
the recombinant protein (7). A band of 50-55 kDa was recognized
in samples 1, 6 and 7 by reaction with peroxidase-labeled species-
specific secondary antibodies, followed by chemiluminiscence
detection.
Figure 6 Localization of bovipain-2 in merozoites. Erythrocytes
infected with B. bovis strain BboS2P (A, D, E); B. bovis, strain RAD (B);
B. bigemina, Mexico strain (C), or non infected erythrocytes (F) were
incubated with murine anti-bovipain-2 antibodies (A, B, C, F); anti-B.
bovis RAP-1 monoclonal antibody 23/70.174 (D) or pre-immune
murine serum (E); followed by detection with FITC- (A,D,E,F) or Alexa
Fluor 488- (B,C) labeled anti-murine IgG, and observation by
epifluorescene, with 400 × (A,D,E,F) or 1000 × magnification (B,C).
Bovipain-2-associated fluorescence was observed as a round spot
inside merozoites and within the erythrocyte cytoplasm (A,B,C),
different from the punctuated fluorescence associated to RAP-1 (D).
No cross-reactivity with erythrocyte proteins was detected (F); and
no unspecific reaction was observed with pre-immune mouse
serum (E).
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Page 7 of 12released into the erythrocyte cytoplasm. Occasionally,
some erythrocytes in which no parasites could be
detected showed cytoplasmic reactivity in smears of
B. bovis-infected erythrocytes (data not shown). Since
non-infected erythrocyte smears showed no reactivity
with anti-bovipain-2 antibodies, a possible explanation
for this observation is that the parasites egressed from
the reactive erythrocytes before the smears were pre-
pared, leaving released proteins behind. Reactivity
towards empty erythrocytes of antibodies that recognize
babesial proteins was previously observed in the case of
the merozoite spherical body protein, Bb-1, which can
be found on the cytoplasmic side of the erythrocyte
membrane [34]. It has been suggested that Bb-1 is
secreted by B. bovis into the erythrocyte cytoplasm,
where it might be involved in invasion and/or exit
processes.
Anti-bovipain-2 antibodies cross-reacted with B. bige-
mina merozoites. A 48.5% identity in the predicted
amino acid sequences of bovipain-2 and a putative
B. bigemina protein named babesipain [35,36] (Table 2)
could be responsible for the observed cross-reactivity.
The cytoplasm of B. bigemina-infected erythrocytes also
reacted with anti-bovipain-2 antibodies, suggesting that
release of babesipain from B. bigemina merozoites has
also taken place.
Expression of cysteine proteases in cultured, wild type
or attenuated B. bovis parasites can be affected by dis-
tinct possible selective pressures. This is significant
since the pattern and level of expression of cysteine pro-
teases were also regarded as potential factors affecting
the virulence of parasites [18]. Sera from bovines experi-
mentally infected either with the BboS2P or BboR1A
Argentinean strains reacted with the recombinant bovi-
pain-2, confirming in vivo expression and immunogeni-
city of the protein in the blood stages of the parasites
regardless of their degree of virulence.
However, because four out of six sera from infected
animals tested failed to recognize recombinant bovipain-
2, the results also suggest that bovipain-2 might be
poorly immunogenic during acute infection. It has been
reported that subdominant antigens may prove to be
more effective as vaccine candidates than immunodomi-
nant antigens [37]. Based on this supposition, bovipain-
2 constitutes an interesting candidate for subunit
vaccine development. Alternatively, it is possible that
these sera also contain antibodies reactive with confor-
mational epitopes in the native protein that are not able
to recognize the recombinant version of bovipain-2.
In silico analysis of the B. bovis predicted proteome
using the MEROPS database has shown the presence of
66 proteases, that belong to the cysteine (n = 18), serine
(n = 18), metallo (n = 19), threonine (n = 6) and aspar-
tic (n = 5) classes (manuscript in preparation). Although
this number is small compared to P. falciparum (n =
93), the high number of protease-encoding genes
appears to indicate that these enzymes participate in cri-
tical metabolic processes and/or signalling mechanisms
that need to be separately regulated. On-going experi-
ments to analyze which of these proteases are tran-
scribed in the merozoite and other stages of the parasite
life cycle will throw light on their possible functional
roles and their suitability as targets for improved control
methods for bovine babesiosis.
Conclusions
Collectively, the data presented in this study identifies
and demonstrates the in vitro and in vivo expression of
bovipain-2, a cysteine protease, in Babesia bovis.
Because this family of proteases plays significant roles in
the biology of related parasites, they might become addi-
tional targets for improving the control of bovine babe-
siosis. Whether antibodies against bovipain-2 present
during natural infection reduce the parasite burden and
whether this protein is a viable candidate for vaccine
development or for new anti-babesial drugs will be the
subject of future research.
Methods
Bioinformatic analysis
C1 cysteine peptidases were identified from the proteome
as predicted by the genome of Babesia bovis (T2Bo
strain), Theileria annulata (Ankara strain) and T. parva
(Mumuga strain) [38] using the MEROPS database
[6,39]. Orthology was established when the complete
genome sequence of the corresponding organism was
available using reciprocal BLASTP best hit [40]. Percen-
tages of protein identity were calculated using a BLO-
SUM62 matrix. Possible deleterious effects of amino acid
substitutions on protein function were predicted by SIFT
[41,42]; which takes into account sequence homology
and the physical properties of amino acids. After align-
ment of the amino acid sequences of the catalytic region
of cysteine proteinases of B. bovis, T. annulata and
T. parva by clustalw [43], their phylogenetic relationship
was constructed by neighbor joining using MEGA4
[44,45]. Synteny studies were carried out with GEvo
[46,47]. Parameter settings using BLASTZ were as fol-
lows: word size 8, gap opening penalty 400, gap extension
penalty 30, and score threshold 1800. The minimum high
scoring sequence pair (HSP) length for overlapped fea-
tures was set to 50. For the prediction of glycosylation,
NetNGlyc and NetOGlyc were used [48-50].
Samples and DNA extraction
The following B. bovis strains and isolates were used:
BboR1A, an Argentine vaccinial strain [51]; BboS2P and
BboM3P, pathogenic isolates derived from clinical cases
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cruz, a pathogenic isolate from Mexico [52]; Brazil and
Uruguay, which originated from clinical cases from
these countries.
BboR1A and BboS2P strains were maintained in
in vitro culture on bovine erythrocytes in M199 medium,
supplemented with 40% bovine serum, at 37°C, basically
as described by Levy and Ristic [53] but using a regular
10% CO2 atmosphere. BboM3P, Brazil, Uruguay and Ver-
acruz isolates were amplified in splenectomized calves.
In vitro cultured merozoites were partially purified by dif-
ferential centrifugation as previously described [54]. In
the case of parasites amplified in splenectomized calves,
whole blood was centrifuged (3000 × g, 30 min, 4°C), the
pellet was frozen at -20°C overnight, and then washed
thrice with PBS by centrifugation (3000 × g, 30 min, 4°C)
to remove released hemoglobin. DNA was purified from
both kinds of samples with phenol/chloroform/isoamylic
alcohol (Sigma-Aldrich, St. Louis, MO) extraction and
ethanol precipitation, using established procedures [55],
followed by RNAse (USB, Cleveland, OH; 20 μg/ml, 45
min, 45°C) and proteinase K (USB; 100 μg/ml, overnight,
45°C) treatment. DNA samples were re-extracted, dis-
solved in distilled water, quantified by spectrophotome-
try, and kept at -20°C until use.
PCR amplification
An aliquot of DNA (50 ng) was added to a PCR mix (25 μl
final volume) containing 2 mM Cl2Mg, 200 μM each
dNTP, 1 U Taq polymerase (Invitrogen) and 0.4 μM bovi-
pain-F and bovipain-R primers (5’-ATGGAAA-
TACCGGCTGCTG-3’ and 5’-ATATGGGACATAAC
CGTAAG-3’, respectively). After 10 min incubation at
95°C, samples were subjected to 35 cycles of: 60 s at 95°C,
45 s at 55°C and 60 s at 72°C, followed by an extension
period of 10 min at 72°C. Amplicons were visualized in
ethidium bromide-stained 0.8% agarose gels and sized by
comparison with a 1 kb Plus DNA ladder (Invitrogen).
RNA extraction
Total RNA was extracted from 5 × 10
6 infected erythro-
cytes of in vitro cultured B. bovis BboS2P and BboR1A
parasites, using the NucleoSpin RNAII kit (Macherey-
Nagel, Germany), according to the manufacturer’s
instructions. RNA integrity was protected with 1 U/ul of
Riboblock (Fermentas, Burlington, Canada). Samples
were then treated with DNAse (Invitrogen) for 15 min at
room temperature, followed by addition of 2 mM EDTA
and incubation at 65°C for 10 min for DNAse inactiva-
tion. The final samples were kept at -80°C until use.
RT-PCR
RNA aliquots (150 ng) from either the BboS2P or
the BboR1A strain of B. bovis were incubated with
SuperScript III One-Step RT-PCR with Platinum Taq
DNA Polymerase (Invitrogen), 2× reaction mix (follow-
ing the manufacturer’sp r o t o c o l ) ,a n d0 . 4μM of bovi-
pain-F and bovipain-R primers in a final reaction
volumen of 25 μl. Parallel negative controls were pre-
pared, containing the same composition without Reverse
Transcriptase. As positive control, primers that amplify
t h eM S A - 2 ct r a n s c r i p t[ 2 8 ]w e r eu s e dw i t ht h es a m e
RNA samples. All samples were incubated for 30 min at
55°C, followed by 2 min at 94°C and then subjected to
40 cycles of 45 s at 94°C, 45 s at 55°C and 60 s at 68°C,
with a final extension period of 5 min at 68°C. Ampli-
cons were visualized and sized as described above.
Sequencing
PCR and RT-PCR amplicons were purified using the
GFX PCR DNA and Gel Band Purification kit (GE
Healthcare), and both strands were sequenced using
specific primers, at the Internal Service of Genotyping
and Sequencing Ibiotec (Institute of Biotechnology, CIC-
VyA, INTA-Castelar, Argentina). The Big Dye Termina-
tor v3.1 kit (Applied Biosystems, Carlsbad, CA, USA)
and a 3130xl Genetic Analyzer equipment (Applied Bio-
systems) were employed.
Expression and purification of recombinant bovipain-2
The entire bovipain-2 ORF, amplified by PCR from
DNA of B. bovis BboR1A was cloned into pCR2.1 vector
(Invitrogen). The correct reading frame of the recombi-
nant construct was verified by sequencing. After diges-
tion of bovipain-2-pCR2.1 with EcoRI (Promega,
Madison, WI), the restriction fragment was purified
using GFX PCR DNA and Gel Band Purification kit (GE
Healthcare) and cloned in-frame in the prokaryotic
expression vector pRSETB (Invitrogen). E. coli Rosetta
(DE3, Novagen) cells were transformed with the recom-
binant vector and expression was induced by overnight
exposure to 1 mM IPTG (Invitrogen) in Luria Broth
medium containing 50 μg/ml ampicillin and 35 μg/ml
chloramphenicol (Sigma-Aldrich). Cells were pelleted by
centrifugation and the pellet was solubilized in Laemmli
buffer. Aliquots of this lysate were electrophoresed in
preparative 12% polyacrylamide minigels in the presence
of SDS. A protein molecular weight marker (Fermentas)
was run in parallel to size the bands. Gel sections con-
taining 50-55 kDa proteins were excised, and placed in
a cellulose membrane dialysis tubing retaining proteins
of molecular weight of 12 kDa or greater (Sigma-
Aldrich). Proteins were electroeluted in a horizontal
electrophoresis chamber at 35 mA for 2.5 h in SDS-
PAGE running buffer, followed by dialysis against PBS.
For Western blots, samples were 5× concentrated
inside the dialysis membranes by exposure to solid
sucrose at room temperature, followed by dialysis
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(Calbiochem, San Diego, CA) was added, protein con-
centration was measured by the Micro BCA Protein
Assay Kit (Pierce, Rockford, USA), and samples were
stored at -80°C until use.
Production of antisera
A d u l tm a l eB a l b - cm i c e( n=2 )w e r ei n o c u l a t e dw i t h
bovipain-2, produced and partially purified by electroe-
lution as described above, emulsified in Sigma Adjuvant
System (Sigma-Aldrich). Inoculations took place at days
0, 20, 40 and 55 and each consisted in 200 μle m u l s i o n ,
containing 50 μg of protein, which were administered in
several spots through the subcutaneous and intraperito-
neal routes. Hyperimmune serum aliquots were col-
lected by heart puncture at day 70 p.i. after euthanizing
the mice with CO2.
Detection of bovipain-2 expression in in vitro cultured
merozoites
In vitro-cultured B. bovis BboS2P merozoites were puri-
fied by centrifugation in Percoll gradients as described
before [54]. Samples containing 7 μg of protein were
dissolved in Laemmli buffer, electrophoresed in 10%
polyacrylamide minigels in the presence of SDS, and
transferred to nitrocellulose membranes. A protein
molecular weight standard from Fermentas was run in
the same gels. Blots were blocked with 10% (w/v) dry
low-fat milk in PBS/0.01% Tween-20 (PBST) and incu-
bated with a pool of mouse anti-bovipain-2 hyperim-
mune serum (day 70 p.i.), or with a pool of serum
obtained at day 0 from the same mice (1/50 dilution in
blocking buffer). After three washes with PBST, reactiv-
ity of antibodies with merozoite proteins was detected
by incubation with peroxidase-labeled anti-mouse IgG
(Santa Cruz Biotechnologies, CA) followed by ECL
reagent (GE Healthcare). Chemiluminiscence was visua-
lized on Hyperfilm sheets (GE Healthcare) developed
with Kodak photographic reagents (Rochester, NY).
Reactivity against bovipain-2 of sera from B. bovis-
infected cattle
Partially purified recombinant bovipain-2 obtained as
described above was electrophoresed in 12% polyacryla-
mide gels in the presence of SDS, followed by transfer
to nitrocellulose membranes, blocking as above, and
incubation with the following sera: a) monoclonal anti-
histidine antibody (GE Healthcare); b) bovine sera nega-
tive to B. bovis antibodies from a tick-free region of
Argentina (n = 2); or c) sera of bovines experimentally
infected with B. bovis BboR1A (n = 3) or BboS2P (n =
3), (day 63 p.i.). Sera from groups (b) and (c) were pre-
incubated with an E. coli lysate (0.1 mg/ml, 37°C, 1 h).
Bovine sera were tested in 1/10 dilution. Blot (a) was
incubated with peroxidase-labeled anti-mouse IgG, and
blots (b) and (c) with peroxidase-labeled anti-bovine IgG
(Santa Cruz Biotechnologies) and the reactions were
visualized by ECL chemiluminiscence. As positive con-
trol, recombinant B. bovis MSA-2c [28] was used.
Indirect immunofluorescence assay
Aliquots (5 ml) of in vitro cultured suspensions of B.
bovis merozoites in bovine erythrocytes (10-15% infected
erythrocytes) from the strains BboS2P (Argentina) or
RAD (Mexico); or with in vitro cultures of B. bigemina,
strains BbiS2P or Mexico, were washed thrice with PBS
by centrifugation and resuspended in PBS/0.5% normal
horse serum. Smears of these suspensions or of non
infected erythrocytes (5 μl) were prepared, divided in
sections with Enamel paint and incubated with: a) nor-
mal mouse serum in a 1/60 dilution; b) a pool of two
anti-bovipain-2 mouse sera (70 dpi) in the same dilu-
tion; and c) anti-RAP-1 23/70.174 Mab [27], 8 μg/ml.
The fixed immunofluorescence assay was carried out as
described before [56], using fluorescein isothiocyanate
(FITC)-labeled goat anti-mouse IgG (Dacko, Glostrup,
Denmark), or donkey anti-mouse Alexa Fluor 488
(Molecular Probes, Invitrogen, Eugene, OK). Slides were
mounted with glycerol/PBS (1:1, v/v) and observed
under fluorescence microscopy (400 and 1000 ×
magnification).
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